Granules India share news, announcements and annual reports
NSE: GRANULESBSE: 532482Pharmaceuticals & BiotechnologySmall Cap
Granules India Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2002 on BSE, Jun 2005 on NSE
Last close ₹837.35down ₹3.10 (0.37%)BSE ₹836.60
Share price at the NSE close on 29 Oct 2026. Previous close ₹840.45.
29 Oct: open ₹840.00, high ₹842.85, low ₹820.00
52-week range of traded prices to 29 Oct 2026
₹529.85Low, 25 Nov 2025₹923.65High, 15 Sep 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22,841 Cr403rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.49
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.21%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,08,57563.3% delivered
Granules India orders, deals and press releases
208 filed, newest first. Page 3 of 5.
Mar 2019
Oct 2018
Sep 2018
Jun 2018
May 2018
Feb 2018
Nov 2017
Sep 2017
Jul 2017
24 Jul · Business
May 2017
Jan 2017
Dec 2016
Nov 2016
Oct 2016
Sep 2016
Aug 2016
Jul 2016
Jun 2016
May 2016
Apr 2016
Mar 2016
Feb 2016
Jan 2016
Dec 2015
Oct 2015
Sep 2015
Aug 2015
Jul 2015
Jun 2015
May 2015
Apr 2015
Jan 2015
Nov 2014
13 Nov · Business
Hon ble High Court of Judicature at Hyderabad for the State of Telangana & Andhra Pradesh has sanctioned the Scheme of Amalgamation whereby Auctus Pharma Limited (Transferor Company & Wholly - Owned Subsidiary) stands amalgamated with Granules India Limited (Transferee Company). Certified true copy of the Court order dated September 23, 2014 has been received on November 11, 2014 and the same was filed with Registrar of Companies, Hyderabad on November 13, 2014. Consequent to the above, the Scheme has become effective on November 13, 2014 with appointed date being April 01, 2013.
Oct 2014
Sep 2014
1 Sep · Business
Share Transfer & Stakeholders Relationship Committe at their meeting held on Septmeber 1, 2014 have approved to allot 40,000 equity shares in consequent to exercise of options under ESOP 2009.1 Sep · Business
Share Transfer & Stakeholders Relationship Committe at their meeting held on Septmebt 1, 2014 have approved to allot equity shares in consequent to exercise of options under ESOP 2009.